These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10099035)

  • 21. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System.
    Hulse G; Kelty E; Hood S; Norman A; Basso MR; Reece AS
    Curr Pharm Des; 2015; 21(23):3325-42. PubMed ID: 26088116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of acute hepatic encephalopathy with flumazenil].
    Viel E; de La Coussaye JE; Bassoul B; Saissi G; Eledjam JJ
    Ann Fr Anesth Reanim; 1990; 9(4):386-9. PubMed ID: 2119157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzodiazepine-like substances and hepatic encephalopathy : implications for treatment.
    Cossar JA; Hayes PC; O'Carroll RE
    CNS Drugs; 1997 Aug; 8(2):91-101. PubMed ID: 23338214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.
    Meyer HP; Legemate DA; van den Brom W; Rothuizen J
    Metab Brain Dis; 1998 Sep; 13(3):241-51. PubMed ID: 9804368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy.
    Steindl P; Püspök A; Druml W; Ferenci P
    Hepatology; 1991 Dec; 14(6):963-8. PubMed ID: 1660024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
    Ferenci P; Grimm G; Meryn S; Gangl A
    Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flumazenil in the treatment of hepatic encephalopathy.
    Howard CD; Seifert CF
    Ann Pharmacother; 1993 Jan; 27(1):46-8. PubMed ID: 8431621
    [No Abstract]   [Full Text] [Related]  

  • 32. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
    Mullen KD; Martin JV; Mendelson WB; Bassett ML; Jones EA
    Lancet; 1988 Feb; 1(8583):457-9. PubMed ID: 2893876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
    Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A
    Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
    Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
    Zeneroli ML
    J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
    Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA
    Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA
    Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract]   [Full Text] [Related]  

  • 38. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.
    Amodio P; Marchetti P; Del Piccolo F; Beghi A; Comacchio F; Carraro P; Campo G; Baruzzo L; Marchiori C; Gatta A
    Clin Physiol; 1997 Sep; 17(5):533-9. PubMed ID: 9347201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
    Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.